<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36430303</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>22</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>10</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Long Chain N3-PUFA Decreases ACE2 Protein Levels and Prevents SARS-CoV-2 Cell Entry.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">13825</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms232213825</ELocationID><Abstract><AbstractText>Angiotensin-converting enzyme 2 (ACE2) is a target of interest for both COVID-19 and cardiovascular disease management. Even though lower ACE2 levels may be beneficial in SARS-CoV-2 infectivity, maintaining the ACE1/ACE2 balance is also crucial for cardiovascular health. So far, reports describing conditions capable of altering ACE2 protein levels, especially via dietary components, are limited. In this study, the effects of omega-3 polyunsaturated fatty acids (n3-PUFA) on the protein levels of ACE1 and ACE2 in rodent tissues, human endothelial and kidney cell lines, and human plasma were examined. The ability of n3-PUFA to affect the entry of the SARS-CoV-2 pseudovirus into cells was also tested. Docosahexaenoic acid (DHA), and in some cases eicosapentaenoic acid (EPA), but not &#x3b1;-linoleic acid (ALA), reduced both ACE1 and ACE2 (non-glycosylated p100 and glycosylated p130 forms) in the heart, aorta, and kidneys of obese rats, as well as in human EA.hy926 endothelial and HEK293 kidney cells. Dietary supplementation with either DHA or ALA had no effect on plasma soluble ACE2 levels in humans. However, treatment of HEK293 cells with 80 and 125 &#xb5;M DHA for 16 h inhibited the entry of the SARS-CoV-2 pseudovirus. These results strongly suggest that DHA treatment may reduce the ability of SARS-CoV-2 to infect cells via a mechanism involving a decrease in the absolute level of ACE2 protein as well as its glycosylation. Our findings warrant further evaluation of long-chain n3-PUFA supplements as a novel option for restricting SARS-CoV-2 infectivity in the general population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Shiqi</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4063-8706</Identifier><AffiliationInfo><Affiliation>Department of Food and Human Nutritional Sciences, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Canadian Centre for Agri-Food Research in Health and Medicine, St. Boniface Hospital Albrechtsen Research Centre, Winnipeg, MB R2H 2A6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Carla G</ForeName><Initials>CG</Initials><Identifier Source="ORCID">0000-0003-3358-6418</Identifier><AffiliationInfo><Affiliation>Department of Food and Human Nutritional Sciences, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Canadian Centre for Agri-Food Research in Health and Medicine, St. Boniface Hospital Albrechtsen Research Centre, Winnipeg, MB R2H 2A6, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology and Pathophysiology, University of Manitoba, Winnipeg, MB R3E 0W2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zahradka</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-7814-0658</Identifier><AffiliationInfo><Affiliation>Department of Food and Human Nutritional Sciences, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Canadian Centre for Agri-Food Research in Health and Medicine, St. Boniface Hospital Albrechtsen Research Centre, Winnipeg, MB R2H 2A6, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology and Pathophysiology, University of Manitoba, Winnipeg, MB R3E 0W2, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Research Without Borders</GrantID><Agency>St. Boniface Hospital Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>25167-62-8</RegistryNumber><NameOfSubstance UI="D004281">Docosahexaenoic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015525">Fatty Acids, Omega-3</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="C000705329">Ace2 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="C000705307">ACE2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004281" MajorTopicYN="N">Docosahexaenoic Acids</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015525" MajorTopicYN="Y">Fatty Acids, Omega-3</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053586" MajorTopicYN="N">Virus Internalization</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE1</Keyword><Keyword MajorTopicYN="N">ACE2</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">omega-3 fatty acids</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>26</Day><Hour>1</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36430303</ArticleId><ArticleId IdType="pmc">PMC9695276</ArticleId><ArticleId IdType="doi">10.3390/ijms232213825</ArticleId><ArticleId IdType="pii">ijms232213825</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . EPI-Win &amp; Infodemic. Clinical Long-Term Effects of COVID-19. World Health Organization; Geneva, Switzerland: 2021. pp. 1&#x2013;15.</Citation></Reference><Reference><Citation>Siddiqi H.K., Libby P., Ridker P.M. COVID-19&#x2014;A vascular disease. Trends Cardiovasc. Med. 2021;31:1&#x2013;5. doi: 10.1016/j.tcm.2020.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2020.10.005</ArticleId><ArticleId IdType="pmc">PMC7556303</ArticleId><ArticleId IdType="pubmed">33068723</ArticleId></ArticleIdList></Reference><Reference><Citation>Menez S., Parikh C.R. Overview of acute kidney manifestations and management of patients with COVID-19. Am. J. Physiol.&#x2014;Ren. Physiol. 2021;321:F403&#x2013;F410. doi: 10.1152/ajprenal.00173.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00173.2021</ArticleId><ArticleId IdType="pmc">PMC8453347</ArticleId><ArticleId IdType="pubmed">34448642</ArticleId></ArticleIdList></Reference><Reference><Citation>Glowacka M., Lipka S., Mlynarska E., Franczyk B., Rysz J. Acute Kidney Injury in COVID-19. Int. J. Mol. Sci. 2021;22:8081. doi: 10.3390/ijms22158081.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22158081</ArticleId><ArticleId IdType="pmc">PMC8347536</ArticleId><ArticleId IdType="pubmed">34360866</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Zhong X., Wang Y., Zeng X., Luo T., Liu Q. Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis. PLoS ONE. 2021;16:e0250602. doi: 10.1371/journal.pone.0250602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0250602</ArticleId><ArticleId IdType="pmc">PMC8092779</ArticleId><ArticleId IdType="pubmed">33939733</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A., Narayan R.K., Kumari C., Faiq M.A., Kulandhasamy M., Kant K., Pareek V. SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients. Med. Hypotheses. 2020;145:110320. doi: 10.1016/j.mehy.2020.110320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110320</ArticleId><ArticleId IdType="pmc">PMC7525265</ArticleId><ArticleId IdType="pubmed">33032170</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y., Ji W., Yang H., Chen S., Zhang W., Duan G. Endothelial activation and dysfunction in COVID-19: From basic mechanisms to potential therapeutic approaches. Signal Transduct. Target. Ther. 2020;5:293. doi: 10.1038/s41392-020-00454-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00454-7</ArticleId><ArticleId IdType="pmc">PMC7758411</ArticleId><ArticleId IdType="pubmed">33361764</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033&#x2013;1034. doi: 10.1016/S0140-6736(20)30628-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417&#x2013;1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Hikmet F., M&#xe9;ar L., Edvinsson &#xc5;., Micke P., Uhl&#xe9;n M., Lindskog C. The protein expression profile of ACE2 in human tissues. Mol. Syst. Biol. 2020;16:e9610. doi: 10.15252/msb.20209610.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.20209610</ArticleId><ArticleId IdType="pmc">PMC7383091</ArticleId><ArticleId IdType="pubmed">32715618</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheblawi M., Wang K., Viveiros A., Nguyen Q., Zhong J.-C., Turner A.J., Raizada M.K., Grant M.B., Oudit G.Y. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Circ. Res. 2020;126:1456&#x2013;1474. doi: 10.1161/CIRCRESAHA.120.317015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317015</ArticleId><ArticleId IdType="pmc">PMC7188049</ArticleId><ArticleId IdType="pubmed">32264791</ArticleId></ArticleIdList></Reference><Reference><Citation>Toe Q.K., Issitt T., Mahomed A.S., Panselinas I., Almaghlouth F., Burke-Gaffney A., Wort S.J., Quinlan G.J. Human pulmonary artery endothelial cells upregulate ACE2 expression in response to iron-regulatory elements: Potential implications for SARS-CoV-2 infection of vascular endothelial cells. bioRxiv. 2021 doi: 10.1002/pul2.12068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pul2.12068</ArticleId><ArticleId IdType="pmc">PMC9063967</ArticleId><ArticleId IdType="pubmed">35514788</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuba K., Imai Y., Rao S., Gao H., Guo F., Guan B., Huan Y., Yang P., Zhang Y., Deng W., et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 2005;11:875&#x2013;879. doi: 10.1038/nm1267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1267</ArticleId><ArticleId IdType="pmc">PMC7095783</ArticleId><ArticleId IdType="pubmed">16007097</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriram K., Insel P.A. A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance. Br. J. Pharmacol. 2020;177:4825&#x2013;4844. doi: 10.1111/bph.15082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15082</ArticleId><ArticleId IdType="pmc">PMC7572451</ArticleId><ArticleId IdType="pubmed">32333398</ArticleId></ArticleIdList></Reference><Reference><Citation>Yalcin H.C., Sukumaran V., Al-Ruweidi M.K.A.A., Shurbaji S. Do changes in ace-2 expression affect sars-cov-2 virulence and related complications: A closer look into membrane-bound and soluble forms. Int. J. Mol. Sci. 2012;22:6703. doi: 10.3390/ijms22136703.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22136703</ArticleId><ArticleId IdType="pmc">PMC8269184</ArticleId><ArticleId IdType="pubmed">34201415</ArticleId></ArticleIdList></Reference><Reference><Citation>Oz M., Lorke D.E., Kabbani N. A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor. Pharmacol. Ther. 2021;221:107750. doi: 10.1016/j.pharmthera.2020.107750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2020.107750</ArticleId><ArticleId IdType="pmc">PMC7854082</ArticleId><ArticleId IdType="pubmed">33275999</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y., Taylor C.G., Aukema H.M., Zahradka P. Regulation of docosahexaenoic acid-induced apoptosis of confluent endothelial cells: Contributions of MAPKs and caspases. Biochim. Biophys. Acta (BBA)&#x2014;Mol. Cell Biol. Lipids. 2021;1866:158902. doi: 10.1016/j.bbalip.2021.158902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbalip.2021.158902</ArticleId><ArticleId IdType="pubmed">33578050</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y., Taylor C.G., Zahradka P. Modulation of endothelial cell responses and vascular function by dietary fatty acids. Nutr. Rev. 2019;77:614&#x2013;629. doi: 10.1093/nutrit/nuz026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nutrit/nuz026</ArticleId><ArticleId IdType="pubmed">31228246</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogero M.M., Le&#xe3;o M.D.C., Santana T.M., Pimentel M.V.D.M., Carlini G.C., da Silveira T.F., Gon&#xe7;alves R.C., Castro I.A. Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19. Free Radic. Biol. Med. 2020;156:190&#x2013;199. doi: 10.1016/j.freeradbiomed.2020.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2020.07.005</ArticleId><ArticleId IdType="pmc">PMC7350587</ArticleId><ArticleId IdType="pubmed">32653511</ArticleId></ArticleIdList></Reference><Reference><Citation>Darwesh A.M., Bassiouni W., Sosnowski D.K., Seubert J.M. Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications? Pharmacol. Ther. 2021;219:107703. doi: 10.1016/j.pharmthera.2020.107703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2020.107703</ArticleId><ArticleId IdType="pmc">PMC7534795</ArticleId><ArticleId IdType="pubmed">33031856</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng Y.W., Wang P.H., Lee H.-S., Liu B.H., Mersmann H.J., Lin E.C., Ding S.-T. Regulation of the expression of angiotensin-converting enzyme 2 by polyunsaturated fatty acids in porcine adipocytes. J. Anim. Sci. 2010;88:3563&#x2013;3567. doi: 10.2527/jas.2010-2905.</Citation><ArticleIdList><ArticleId IdType="doi">10.2527/jas.2010-2905</ArticleId><ArticleId IdType="pubmed">20622181</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulu A., Harris T.R., Morisseau C., Miyabe C., Inoue H., Schuster G., Dong H., Iosif A.-M., Liu J.-Y., Weiss R.H., et al. Anti-inflammatory effects of &#x3c9;-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension. J. Cardiovasc. Pharmacol. 2013;62:285&#x2013;297. doi: 10.1097/FJC.0b013e318298e460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0b013e318298e460</ArticleId><ArticleId IdType="pmc">PMC3773051</ArticleId><ArticleId IdType="pubmed">23676336</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamagata K. Docosahexaenoic acid regulates vascular endothelial cell function and prevents cardiovascular disease. Lipids Health Dis. 2017;16:1&#x2013;13. doi: 10.1186/s12944-017-0514-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12944-017-0514-6</ArticleId><ArticleId IdType="pmc">PMC5472966</ArticleId><ArticleId IdType="pubmed">28619112</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q., Hughes T.A., Kelkar A., Yu X., Cheng K., Park S., Huang W.-C., Lovell J.F., Neelamegham S. Inhibition of SARS-CoV-2 viral entry upon blocking N-and O-glycan elaboration. Elife. 2020;9:e61552. doi: 10.7554/eLife.61552.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.61552</ArticleId><ArticleId IdType="pmc">PMC7685702</ArticleId><ArticleId IdType="pubmed">33103998</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehdipour A.R., Hummer G. Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike. Proc. Natl. Acad. Sci. USA. 2021;118:e2100425118. doi: 10.1073/pnas.2100425118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2100425118</ArticleId><ArticleId IdType="pmc">PMC8126795</ArticleId><ArticleId IdType="pubmed">33903171</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y., Taylor C.G., Aukema H.M., Zahradka P. Importance of extracellular matrix and growth state for the EA.hy926 endothelial cell response to polyunsaturated fatty acids. PLoS ONE. 2018;13:e0197613. doi: 10.1371/journal.pone.0197613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0197613</ArticleId><ArticleId IdType="pmc">PMC5953484</ArticleId><ArticleId IdType="pubmed">29763471</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung M.L., Teng J.L.L., Jia L., Zhang C., Huang C., Cai J.P., Zhou R., Chen K.-H., Zhao H., Zhu L., et al. Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system. Cell. 2021;184:2212&#x2013;2228.e12. doi: 10.1016/j.cell.2021.02.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.02.053</ArticleId><ArticleId IdType="pmc">PMC7923941</ArticleId><ArticleId IdType="pubmed">33713620</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramchand J., Burrell L.M. Circulating ACE2: A novel biomarker of cardiovascular risk. Lancet. 2020;396:937&#x2013;939. doi: 10.1016/S0140-6736(20)32011-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32011-0</ArticleId><ArticleId IdType="pmc">PMC7529379</ArticleId><ArticleId IdType="pubmed">33010824</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel S.K., Juno J.A., Lee W.S., Wragg K.M., Hogarth P.M., Kent S.J., Burrell L.M. Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: Implications for COVID-19 pathogenesis and consequences. Eur. Respir. J. 2021;57:10&#x2013;12. doi: 10.1183/13993003.03730-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03730-2020</ArticleId><ArticleId IdType="pmc">PMC7830336</ArticleId><ArticleId IdType="pubmed">33479113</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundstr&#xf6;m A., Ziegler L., Havervall S., Rudberg A., von Meijenfeldt F., Lisman T., Mackman N., Sand&#xe9;n P., Th&#xe5;lin C. Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers. J. Med. Virol. 2021;93:5908&#x2013;5916. doi: 10.1002/jmv.27144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27144</ArticleId><ArticleId IdType="pmc">PMC8426677</ArticleId><ArticleId IdType="pubmed">34138483</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagyas M., Fejes Z., S&#xfc;t&#x151; R., Nagy Z., Sz&#xe9;kely B., P&#xf3;csi M., Iv&#xe1;dy G., B&#xed;r&#xf3; E., Bek&#x151; G., Nagy A., et al. Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients. Int. J. Infect. Dis. 2022;115:8&#x2013;16. doi: 10.1016/j.ijid.2021.11.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.11.028</ArticleId><ArticleId IdType="pmc">PMC8613979</ArticleId><ArticleId IdType="pubmed">34838959</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabbs M., Zahradka P., Taylor C.G., Aukema H.M. Time Course and Sex Effects of &#x3b1;-Linolenic Acid-Rich and DHA-Rich Supplements on Human Plasma Oxylipins: A Randomized Double-Blind Crossover Trial. J. Nutr. 2021;151:513&#x2013;522. doi: 10.1093/jn/nxaa294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/nxaa294</ArticleId><ArticleId IdType="pmc">PMC7948207</ArticleId><ArticleId IdType="pubmed">33097936</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodway L.A., Pauls S.D., Aukema H.M., Zahradka P., Taylor C.G. Rationale and design of a randomized controlled trial examining the effects of marine- and plant-sourced omega-3 fatty acid supplements on octadecanoid profiles and inflammation in females with obesity (OXBIO trial) Prostaglandins Leukot. Essent. Fat. Acids. 2021;170:102284. doi: 10.1016/j.plefa.2021.102284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plefa.2021.102284</ArticleId><ArticleId IdType="pubmed">34051428</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen J., Reimer K.C., Nagai J.S., Varghese F.S., Overheul G.J., de Beer M., Roverts R., Daviran D., Fermin L.A.S., Willemsen B., et al. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Cell Stem Cell. 2022;29:217&#x2013;231.e8. doi: 10.1016/j.stem.2021.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2021.12.010</ArticleId><ArticleId IdType="pmc">PMC8709832</ArticleId><ArticleId IdType="pubmed">35032430</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin S.K., Kim J.H., Lee J.H., Son Y.H., Lee M.W., Kim H.J., Noh S.A., Kim K.P., Kim I.G., Lee M.J. Docosahexaenoic acid-mediated protein aggregates may reduce proteasome activity and delay myotube degradation during muscle atrophy in vitro. Exp. Mol. Med. 2017;49:e287. doi: 10.1038/emm.2016.133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2016.133</ArticleId><ArticleId IdType="pmc">PMC5291838</ArticleId><ArticleId IdType="pubmed">28104914</ArticleId></ArticleIdList></Reference><Reference><Citation>Morens D.M., Folkers G.K., Fauci A.S. The Concept of Classical Herd Immunity May Not Apply to COVID-19. J. Infect. Dis. 2022;226:195&#x2013;198. doi: 10.1093/infdis/jiac109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac109</ArticleId><ArticleId IdType="pmc">PMC9129114</ArticleId><ArticleId IdType="pubmed">35356987</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh B., Singh D., Verma V., Yadav R., Kumar R. Angiotensin-converting enzyme 2 as a potential therapeutic target for COVID-19: A review. J. Pharm. Anal. 2012;12:215&#x2013;220. doi: 10.1016/j.jpha.2021.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpha.2021.12.003</ArticleId><ArticleId IdType="pmc">PMC8677424</ArticleId><ArticleId IdType="pubmed">34934510</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou J., Zhang Y., Wang Y., Zhang Z., Wei H., Yu J., Wang Q., Wang G., Zhang B., Wang C. ACE2-Targeting antibody suppresses SARS-CoV-2 Omicron and Delta variants. Signal Transduct. Target. Ther. 2022;7:43. doi: 10.1038/s41392-022-00913-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00913-3</ArticleId><ArticleId IdType="pmc">PMC8828746</ArticleId><ArticleId IdType="pubmed">35140198</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulu A., Lee K.S.S., Miyabe C., Yang J., Hammock B.G., Dong H. An omega-3 epoxide of docosahexaenoic acid lowers blood pressure in angiotensin-II-dependent hypertension. J. Cardiovasc. Pharmacol. 2014;64:87&#x2013;99. doi: 10.1097/FJC.0000000000000094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0000000000000094</ArticleId><ArticleId IdType="pmc">PMC4092041</ArticleId><ArticleId IdType="pubmed">24691274</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao P., Praissman J.L., Grant O.C., Cai Y., Xiao T., Rosenbalm K.E., Aoki K., Kellman B.P., Bridger R., Barouch D.H., et al. Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor. Cell Host Microbe. 2020;28:586&#x2013;601.e6. doi: 10.1016/j.chom.2020.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.08.004</ArticleId><ArticleId IdType="pmc">PMC7443692</ArticleId><ArticleId IdType="pubmed">32841605</ArticleId></ArticleIdList></Reference><Reference><Citation>Stupin A., Cvetko A., Kralik G., Mihalj M., &#x160;u&#x161;njara P., Kolobari&#x107; N., &#x106;uri&#x107; &#x17d;.B., Lukinac A.M., Kibel A., Selthofer-Relati&#x107; K., et al. The effect of n-3 polyunsaturated fatty acids-enriched hen eggs consumption on IgG and total plasma protein N-glycosylation in healthy individuals and cardiovascular patients. Glycobiology. 2021;31:1163&#x2013;1175. doi: 10.1093/glycob/cwab051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/glycob/cwab051</ArticleId><ArticleId IdType="pubmed">34132788</ArticleId></ArticleIdList></Reference><Reference><Citation>Weill P., Plissonneau C., Legrand P., Rioux V., Thibault R. May omega-3 fatty acid dietary supplementation help reduce severe complications in Covid-19 patients? Biochimie. 2020;179:275&#x2013;280. doi: 10.1016/j.biochi.2020.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2020.09.003</ArticleId><ArticleId IdType="pmc">PMC7481803</ArticleId><ArticleId IdType="pubmed">32920170</ArticleId></ArticleIdList></Reference><Reference><Citation>Goc A., Niedzwiecki A., Rath M. Polyunsaturated &#x3c9;-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry. Sci. Rep. 2021;11:5207. doi: 10.1038/s41598-021-84850-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84850-1</ArticleId><ArticleId IdType="pmc">PMC7933164</ArticleId><ArticleId IdType="pubmed">33664446</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelmagid S.A., Clarke S.E., Nielsen D.E., Badawi A., El-Sohemy A., Mutch D.M., Ma D.W. Comprehensive profiling of plasma fatty acid concentrations in young healthy canadian adults. PLoS ONE. 2015;10:e0116195. doi: 10.1371/journal.pone.0116195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0116195</ArticleId><ArticleId IdType="pmc">PMC4326172</ArticleId><ArticleId IdType="pubmed">25675440</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang E.I., Syu J.N., Hung H.C., Rodriguez R.L., Wang W.J., Chiang E.R., Chiu S.C., Chao C.Y., Tang F.Y. N-3 polyunsaturated fatty acids block the trimethylamine-N-oxide- ACE2- TMPRSS2 cascade to inhibit the infection of human endothelial progenitor cells by SARS-CoV-2. J. Nutr. Biochem. 2022;109:109102. doi: 10.1016/j.jnutbio.2022.109102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2022.109102</ArticleId><ArticleId IdType="pmc">PMC9264727</ArticleId><ArticleId IdType="pubmed">35817244</ArticleId></ArticleIdList></Reference><Reference><Citation>Far&#xed;as J.G., Carrasco-Pozo C., Carrasco Loza R., Sep&#xfa;lveda N., &#xc1;lvarez P., Quezada M., Qui&#xf1;ones J., Molina V., Castillo R.L. Polyunsaturated fatty acid induces cardioprotection against ischemia-reperfusion through the inhibition of NF-kappaB and induction of Nrf2. Exp. Biol. Med. 2017;242:1104&#x2013;1114. doi: 10.1177/1535370216649263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1535370216649263</ArticleId><ArticleId IdType="pmc">PMC5444634</ArticleId><ArticleId IdType="pubmed">27190274</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T.M., Chen C.J., Lee T.S., Chao H.Y., Wu W.H., Hsieh S.C., Sheu H.H., Chiang A.N. Docosahexaenoic acid attenuates VCAM-1 expression and NF-&#x3ba;B activation in TNF-&#x3b1;-treated human aortic endothelial cells. J. Nutr. Biochem. 2011;22:187&#x2013;194. doi: 10.1016/j.jnutbio.2010.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2010.01.007</ArticleId><ArticleId IdType="pubmed">20573493</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Tian S., Wang Q., Yao S., Qian L., Jiang S., Tang Y., Han T. DHA-enriched phosphatidylserine ameliorates high-fat diet-induced kidney injury in mice possibly by regulating TLR4/NF-&#x3ba;B and AMPK pathways. J. Food Sci. 2022;87:4233&#x2013;4249. doi: 10.1111/1750-3841.16284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1750-3841.16284</ArticleId><ArticleId IdType="pubmed">35986700</ArticleId></ArticleIdList></Reference><Reference><Citation>Saravanan P., Davidson N.C., Schmidt E.B., Calder P.C. Cardiovascular effects of marine omega-3 fatty acids. Lancet. 2010;376:540&#x2013;550. doi: 10.1016/S0140-6736(10)60445-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)60445-X</ArticleId><ArticleId IdType="pubmed">20638121</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghi C., Cicero A.F.G. Omega-3 polyunsaturated fatty acids: Their potential role in blood pressure prevention and management. Heart Int. 2006;2:98&#x2013;105. doi: 10.4081/hi.2006.98.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/hi.2006.98</ArticleId><ArticleId IdType="pmc">PMC3184661</ArticleId><ArticleId IdType="pubmed">21977258</ArticleId></ArticleIdList></Reference><Reference><Citation>Narula S., Yusuf S., Chong M., Ramasundarahettige C., Rangarajan S., Bangdiwala S.I., van Eikels M., Leineweber K., Wu A., Pigeyre M., et al. Plasma ACE2 and risk of death or cardiometabolic diseases: A case-cohort analysis. Lancet. 2020;396:968&#x2013;976. doi: 10.1016/S0140-6736(20)31964-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31964-4</ArticleId><ArticleId IdType="pmc">PMC7529405</ArticleId><ArticleId IdType="pubmed">33010842</ArticleId></ArticleIdList></Reference><Reference><Citation>Kragstrup T.W., Singh H.S., Grundberg I., Nielsen A.L.-L., Rivellese F., Mehta A., Goldberg M.B., Filbin M.R., Qvist P., Bibby B.M. Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients. PLoS ONE. 2021;16:e0252799. doi: 10.1371/journal.pone.0252799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0252799</ArticleId><ArticleId IdType="pmc">PMC8177449</ArticleId><ArticleId IdType="pubmed">34086837</ArticleId></ArticleIdList></Reference><Reference><Citation>Gealekman O., Brodsky S.V., Zhang F., Chander P.N., Friedli C., Nasjletti A., Goligorsky M.S. Endothelial dysfunction as a modifier of angiogenic response in Zucker diabetic fat rat: Amelioration with Ebselen. Kidney Int. 2004;66:2337&#x2013;2347. doi: 10.1111/j.1523-1755.2004.66035.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2004.66035.x</ArticleId><ArticleId IdType="pubmed">15569324</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Salazar B., Holwerda M., St&#xfc;dle C., Piragyte I., Mercader N., Engelhardt B., Rieben R., D&#xf6;ring Y. COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences. Front. Cell Dev. Biol. 2022;10:824851. doi: 10.3389/fcell.2022.824851.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.824851</ArticleId><ArticleId IdType="pmc">PMC8887620</ArticleId><ArticleId IdType="pubmed">35242762</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder P.C. Docosahexaenoic Acid. Ann. Nutr. Metab. 2016;69((Suppl. 1)):7&#x2013;21. doi: 10.1159/000448262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000448262</ArticleId><ArticleId IdType="pubmed">27842299</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong L., Zahradka P., Cordero-Monroy L., Wright B., Taylor C.G. Dietary Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA) Operate by Different Mechanisms to Modulate Hepatic Steatosis and Hyperinsulemia in fa/fa Zucker Rats. Nutrients. 2019;11:917. doi: 10.3390/nu11040917.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11040917</ArticleId><ArticleId IdType="pmc">PMC6521162</ArticleId><ArticleId IdType="pubmed">31022865</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbir M.G., Taylor C.G., Zahradka P. Hypomorphic CAMKK2 in EA.hy926 endothelial cells causes abnormal transferrin trafficking, iron homeostasis and glucose metabolism. Biochim. Biophys. Acta&#x2014;Mol. Cell Res. 2020;1867:118763. doi: 10.1016/j.bbamcr.2020.118763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2020.118763</ArticleId><ArticleId IdType="pubmed">32485269</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>